Doctor examining knee of patient that uses crutches

PPD CorEvitas Rheumatology Registries

Our independent patient registries track information about the health status of patients and the care they receive, bringing together large regulatory-grade proprietary data sets to analyze patterns in treatment and outcomes, informing best practices and treatment decisions.

Developed and maintained under the guidance of scientific advisors who are preeminent experts in their fields, these registries feature exceptional data completeness and scientific rigor.

Now enrolling qualified sites for our rheumatology registries!

Japan Rheumatoid Arthritis

CorEvitas Japan Rheumatoid Arthritis Registry

Obtain data and evidence on the comparative effectiveness and safety of approved therapies for rheumatoid arthritis (RA) in a cohort of Japanese patients treated by rheumatologists. The PPD™ CorEvitas™ Japan RA Registry is a prospective, multi-site, observational, real-world study that collects information on patients with RA.

Explore data from our registry

0 +

Study visits

0 +

Patients

0 +

Rheumatologists

Examples of the robust outcome measures collected

  • Disease Activity Score (DAS28)
  • Clinical Disease Activity Index (CDAI)
  • Simple Disease Activity Index (SDAI)

  • Euro-QoL Group EQ-5D-3L
  • Japanese version of the Health Assessment Questionnaire (J-HAQ)
  • Patient Global Assessment
  • Pain Visual Analogue Scale
  • Morning Stiffness Visual Analogue Scale
  • Fatigue Visual Analogue Scale
  • Work Productivity and Activity Impairment (WPAI)
  • Health care resource utilization

Are you interested in utilizing these data?

Join our Registry Investigator Network to help improve patient health outcomes.

CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

Gain a deeper understanding of the impact of psoriatic arthritis (PsA) and spondyloarthritis on patients’ response to therapy and quality of life, as well as clinician- and patient-reported outcomes detailing persistence patterns and unmet needs associated with the disease and its treatment. The CorEvitas Psoriatic Arthritis / Spondyloarthritis Registry features regulatory-grade real-world data and evidence that can be used to inform research and decision-making.

Explore data from our registry

0 +

Study visits

0 +

Patients

0 +

Rheumatologists

Examples of the robust outcome measures collected

  • SPARCC/Leeds Enthesitis Index
  • Dactylitis

  • American College of Rheumatology Response Criteria (ACR)
  • Disease Activity Score (DAS)
  • Clinical Disease Activity Index (CDAI)
  • Simple Disease Activity Index (SDAI)
  • Psoriatic Arthritis Response Criteria (PsARC)
  • Composite Psoriatic Disease Activity Index (CPDAI)
  • Assessment of Spondyloarthritis International Society (ASAS) scores
  • Ankylosing Spondylitis Disease Activity Score (ASDAS)

  • Work Productivity and Activity Impairment (WPAI)
  • Euro-QoL Group EQ-5D-3L
  • Health Assessment Questionnaire for the Spondyloarthropathies (HAQ-S)
  • Pain Visual Analogue Scale
  • Stiffness Visual Analogue Scale
  • Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)
  • Bath Ankylosing Spondylitis Functional Index (BASFI)
  • Assessment of Spondyloarthritis International Society Health Index (ASAS HI)

Are you interested in utilizing these data?

Join our Registry Investigator Network to help improve patient health outcomes.

Female patient in shoulder joint pain speaking to a doctor

CorEvitas Rheumatoid Arthritis (RA) Registry

Gain insight and fill data voids with robust, longitudinal real-world data from the most extensive rheumatoid arthritis real-world prospective cohort study in the world. Explore regulatory-grade data examining the long-term real-world effectiveness, safety and treatment patterns of approved therapies, including clinician- and patient-reported outcomes. Leverage more than 20 years of deep clinical data and evidence to inform your research and decision-making.

Explore data from our registry

0 +

Study visits

0 +

Patients

0 +

Rheumatologists

Examples of the robust outcome measures collected

  • Disease Activity Score (DAS28)
  • Clinical Disease Activity Index (CDAI)
  • Simple Disease Activity Index (SDAI)

  • Euro-QoL Group EQ-5D-3L
  • Health Assessment Questionnaire (HAQ)
  • Patient Global Assessment
  • Pain Visual Analogue Scale
  • Morning Stiffness Visual Analogue Scale
  • Fatigue Visual Analogue Scale

Are you interested in utilizing these data?

Join our Registry Investigator Network to help improve patient health outcomes.

Lupus patient being seen by a doctor

CorEvitas Systemic Lupus Erythematosus (SLE) Registry

Established in 2025

Gain insight from this prospective registry, leveraging detailed patient-level data on SLE to enable assessment of the natural history of the disease, treatment patterns, real-world safety of medications used, disease burden and unmet needs in patients living with SLE. Granular, longitudinal outcome measures are collected during regular visits, including clinician-reported SLE outcomes, biologics and lab measures, and patient-reported outcomes assessing symptom impact and quality of life.

Explore data from our registry

0 +

Study visits

0 +

Patients

0 +

Rheumatologists

Examples of the robust outcome measures collected

  • 28 Joint Count
  • Hybrid SELENA SLEDAI
  • SELENA-SLEDAI Flare Index
  • SLICC

  • Healthcare resource utilization (outpatient & ER visits, hospitalizations)
  • Pain Numeric Rating Scale (NRS)
  • Fatigue NRS
  • Patient Global NRS
  • European Quality of Life 5 Dimensions 5 Level Version (EQ-5D-5L)
  • Work Productivity and Activity Impairments (WPAI)

Are you interested in utilizing these data?

Join our Registry Investigator Network to help improve patient health outcomes.

Contact our team